Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers.
about
Dengue vaccine: priorities and progress.CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma.Domain III of the envelope protein as a dengue vaccine target.Novel approaches to Neisseria meningitidis vaccine design.Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.
P2860
Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Safety and preliminary immunog ...... ingitidis in human volunteers.
@ast
Safety and preliminary immunog ...... ingitidis in human volunteers.
@en
Safety and preliminary immunog ...... ingitidis in human volunteers.
@nl
type
label
Safety and preliminary immunog ...... ingitidis in human volunteers.
@ast
Safety and preliminary immunog ...... ingitidis in human volunteers.
@en
Safety and preliminary immunog ...... ingitidis in human volunteers.
@nl
prefLabel
Safety and preliminary immunog ...... ingitidis in human volunteers.
@ast
Safety and preliminary immunog ...... ingitidis in human volunteers.
@en
Safety and preliminary immunog ...... ingitidis in human volunteers.
@nl
P2093
P356
P1476
Safety and preliminary immunog ...... ingitidis in human volunteers.
@en
P2093
Caballero E
Dickinson F
González S
Gutiérrez O
Gutiérrez Y
P304
P356
10.1042/BA20010029
P577
2001-10-01T00:00:00Z